Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation

Source:
NIHR Journals Library - Health Technology Assessment
Publisher:
NIHR Journals Library – Health Technology Assessment
Publication date:
01 January 2015

Abstract

(2015) Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation. NIHR Journals Library - Health Technology Assessment: Health Technology Assessment (HTA) publishes research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. Find out more about the HTA journal at https://www.journalslibrary.nihr.ac.uk/hta/#/.